Alfonso Amparo, de la Rosa Laura, Vieytes Mercedes R, Yasumoto Takeshi, Botana Luis M
Departamento de Farmacología, Facultad de Veterinaria, USC, 27002 Lugo, Spain.
Biochem Pharmacol. 2003 Jan 15;65(2):193-208. doi: 10.1016/s0006-2952(02)01454-5.
Yessotoxin (YTX) is a novel phycotoxin with an unknown mechanism of action that has been reported as cardiotoxic, when injected, but non-toxic if ingested orally. In this paper, we studied the effect of YTX on adenosine 3',5'-cyclic monophosphate (cAMP) pathway, since this pathway can be a cellular target to this toxin as happens in other diarrhetic toxins. We determined cAMP levels by enzymeimmunoassay and by using the cAMP dye recombinant fluorescein- and rhodamine-labeled protein kinase A, which increases their fluorescence when cAMP levels are increased. In the presence of YTX, and after a transient small increase, cAMP levels were decreased. This effect was Ca(2+) dependent since in a Ca(2+)-free medium YTX increased cAMP levels, but this event was reverted after addition of external calcium. YTX also reverted the increase of cAMP induced by the adenylyl cyclase activator forskolin. These variations in fluorescence units were confirmed when cAMP levels were measured by enzymeimmunoassay, YTX decreases cAMP from 52.81+/-3.66 to 44.53+/-4.5 fmol. Phosphodiesterase (PDE) IV inhibitors, rolipram or etazolate, did not modify the effect of YTX, however, when PDE IV was first inhibited no effect of YTX was observed. On the other hand, the PDE III inhibitor milrinone counteracted the effect of YTX, and a similar effect was observed with the unspecific PDE I inhibitor chlorpromazine. These results point to an effect of YTX on PDE activity. In the presence of YTX, the fluorescent PDE substrate Mant-cAMP, increased its rate of hydrolysis, the same as the PDE from bovine brain increased the hydrolysis of cAMP substrate. In addition, YTX increased interleukin-2 production, which indirectly confirms a decrease in cAMP. Although results show a very complex pattern of responses, due to the interactions and crosstalks between many systems, results suggest that YTX is a PDE activator in the presence of external Ca(2+).
岩沙海葵毒素(YTX)是一种作用机制不明的新型藻毒素。据报道,注射时它具有心脏毒性,但口服则无毒。在本文中,我们研究了YTX对3',5'-环磷酸腺苷(cAMP)途径的影响,因为该途径可能是这种毒素的细胞靶点,就像其他腹泻毒素的情况一样。我们通过酶免疫测定法以及使用cAMP染料重组荧光素和罗丹明标记的蛋白激酶A来测定cAMP水平,当cAMP水平升高时,它们的荧光会增强。在YTX存在的情况下,经过短暂的小幅升高后,cAMP水平降低。这种效应依赖于Ca(2+),因为在无Ca(2+)的培养基中YTX会增加cAMP水平,但添加外部钙后这种情况会逆转。YTX还能逆转腺苷酸环化酶激活剂福斯高林诱导的cAMP增加。当通过酶免疫测定法测量cAMP水平时,荧光单位的这些变化得到了证实,YTX使cAMP从52.81±3.66降至44.53±4.5 fmol。磷酸二酯酶(PDE)IV抑制剂咯利普兰或依他唑酯并未改变YTX的作用,然而,当PDE IV首先被抑制时,未观察到YTX的作用。另一方面,PDE III抑制剂米力农抵消了YTX的作用,非特异性PDE I抑制剂氯丙嗪也观察到了类似的效果。这些结果表明YTX对PDE活性有影响。在YTX存在的情况下,荧光PDE底物Mant-cAMP的水解速率增加,与牛脑PDE增加cAMP底物的水解情况相同。此外,YTX增加了白细胞介素-2的产生,这间接证实了cAMP的减少。尽管结果显示出非常复杂的反应模式,由于许多系统之间的相互作用和串扰,但结果表明在外部Ca(2+)存在的情况下YTX是一种PDE激活剂。